- Home
- LNTH vs BGC Comparison
LNTH vs BGC Comparison
Compare LNTH & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- BGC
- Stock Information
- Founded
- LNTH 1956
- BGC 1945
- Country
- LNTH United States
- BGC United States
- Employees
- LNTH 808
- BGC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BGC Investment Bankers/Brokers/Service
- Sector
- LNTH Health Care
- BGC Finance
- Exchange
- LNTH Nasdaq
- BGC Nasdaq
- Market Cap
- LNTH 3.8B
- BGC 4.4B
- IPO Year
- LNTH 2015
- BGC 1999
- Fundamental
- Price
- LNTH $56.28
- BGC $9.49
- Analyst Decision
- LNTH Buy
- BGC Strong Buy
- Analyst Count
- LNTH 6
- BGC 2
- Target Price
- LNTH $74.50
- BGC $14.50
- AVG Volume (30 Days)
- LNTH 1.5M
- BGC 2.8M
- Earning Date
- LNTH 11-06-2025
- BGC 11-06-2025
- Dividend Yield
- LNTH N/A
- BGC 0.85%
- EPS Growth
- LNTH N/A
- BGC 38.47
- EPS
- LNTH 3.77
- BGC 0.30
- Revenue
- LNTH $1,520,653,000.00
- BGC $2,473,844,000.00
- Revenue This Year
- LNTH N/A
- BGC $35.74
- Revenue Next Year
- LNTH $2.25
- BGC $11.43
- P/E Ratio
- LNTH $14.86
- BGC $31.25
- Revenue Growth
- LNTH 5.75
- BGC 20.94
- 52 Week Low
- LNTH $47.25
- BGC $7.24
- 52 Week High
- LNTH $118.21
- BGC $11.79
- Technical
- Relative Strength Index (RSI)
- LNTH 55.37
- BGC 54.45
- Support Level
- LNTH $56.03
- BGC $9.03
- Resistance Level
- LNTH $57.94
- BGC $9.57
- Average True Range (ATR)
- LNTH 1.56
- BGC 0.21
- MACD
- LNTH 0.39
- BGC 0.07
- Stochastic Oscillator
- LNTH 79.58
- BGC 90.24
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About BGC BGC Group Inc.
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.